Despite the short-term challenges posed by the COVID-19 pandemic, the European market for interventional oncology devices will grow moderately through 2031. This will be driven largely by the expanding treatable patient populations, improved reimbursement, an increasing shift towards higher-priced technologies, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data, increasing-price competition, and ongoing cost constraints in the region which has led to a tempered adoption of interventional oncology devices.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in Europe from 2019\u20132031.<\/p>\n","protected":false},"template":"","class_list":["post-385960","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-interventional-oncology-devices","medtech-geography-europe","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385960\/revisions"}],"predecessor-version":[{"id":387469,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385960\/revisions\/387469"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}